Literature DB >> 32275114

Western diet-induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis.

Biki Gupta1, Yunshan Liu2, Daniel M Chopyk2, Ravi P Rai1, Chirayu Desai3, Pradeep Kumar2, Alton B Farris4, Asma Nusrat5, Charles A Parkos5, Frank A Anania6, Reben Raeman1,7.   

Abstract

There is compelling evidence implicating intestinal permeability in the pathogenesis of nonalcoholic steatohepatitis (NASH), but the underlying mechanisms remain poorly understood. Here we examined the role of bile acids (BA) in western diet (WD)-induced loss of colonic epithelial barrier (CEB) function in mice with a genetic impairment in intestinal epithelial barrier function, junctional adhesion molecule A knockout mice, F11r-/- . WD-fed knockout mice developed severe NASH, which was associated with increased BA concentration in the cecum and loss of CEB function. Analysis of cecal BA composition revealed selective increases in primary unconjugated BAs in the WD-fed mice, which correlated with increased abundance of microbial taxa linked to BA metabolism. In vitro permeability assays revealed that chenodeoxycholic acid (CDCA), which was elevated in the cecum of WD-fed mice, increased paracellular permeability, while the BA-binding resin sevelamer hydrochloride protected against CDCA-induced loss of barrier function. Sequestration of intestinal BAs by in vivo delivery of sevelamer to WD-fed knockout mice attenuated colonic mucosal inflammation and improved CEB. Sevelamer also reduced hepatic inflammation and fibrosis, and improved metabolic derangements associated with NASH. Collectively, these findings highlight a hitherto unappreciated role for BAs in WD-induced impairment of the intestinal epithelial barrier in NASH.
© 2020 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  NAFLD; NASH; bile acids; intestinal permeability; microbiome; tight junction

Mesh:

Substances:

Year:  2020        PMID: 32275114      PMCID: PMC7831197          DOI: 10.1096/fj.201902687R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  50 in total

Review 1.  Guts and Gall: Bile Acids in Regulation of Intestinal Epithelial Function in Health and Disease.

Authors:  Peter Hegyi; Joszef Maléth; Julian R Walters; Alan F Hofmann; Stephen J Keely
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

2.  Composition of cecal bile acids in ex-germfree mice inoculated with human intestinal bacteria.

Authors:  S Narushima; K Ito; K Kuruma; K Uchida
Journal:  Lipids       Date:  2000-06       Impact factor: 1.880

Review 3.  Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.

Authors:  Detlef Schuppan; Jörn M Schattenberg
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

Review 4.  The role of bile acids in carcinogenesis.

Authors:  P R Debruyne; E A Bruyneel; X Li; A Zimber; C Gespach; M M Mareel
Journal:  Mutat Res       Date:  2001-09-01       Impact factor: 2.433

5.  Bile acid modulates transepithelial permeability via the generation of reactive oxygen species in the Caco-2 cell line.

Authors:  Yoshio Araki; Takuji Katoh; Atsushi Ogawa; Shigeki Bamba; Akira Andoh; Shigeki Koyama; Yoshihide Fujiyama; Tadao Bamba
Journal:  Free Radic Biol Med       Date:  2005-09-15       Impact factor: 7.376

6.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

Authors:  Luca Miele; Venanzio Valenza; Giuseppe La Torre; Massimo Montalto; Giovanni Cammarota; Riccardo Ricci; Roberta Mascianà; Alessandra Forgione; Maria L Gabrieli; Germano Perotti; Fabio M Vecchio; Gianlodovico Rapaccini; Giovanni Gasbarrini; Chris P Day; Antonio Grieco
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

7.  Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.

Authors:  Anuradha Rao; Astrid Kosters; Jamie E Mells; Wujuan Zhang; Kenneth D R Setchell; Angelica M Amanso; Grace M Wynn; Tianlei Xu; Brad T Keller; Hong Yin; Sophia Banton; Dean P Jones; Hao Wu; Paul A Dawson; Saul J Karpen
Journal:  Sci Transl Med       Date:  2016-09-21       Impact factor: 17.956

8.  Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation.

Authors:  Francesco Raimondi; Pasquale Santoro; Maria Vittoria Barone; Serena Pappacoda; Maria Luisa Barretta; Merlin Nanayakkara; Carmela Apicella; Letizia Capasso; Roberto Paludetto
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-01-31       Impact factor: 4.052

9.  Carcinogenicity of deoxycholate, a secondary bile acid.

Authors:  Carol Bernstein; Hana Holubec; Achyut K Bhattacharyya; Huy Nguyen; Claire M Payne; Beryl Zaitlin; Harris Bernstein
Journal:  Arch Toxicol       Date:  2011-01-26       Impact factor: 5.153

Review 10.  Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.

Authors:  Chris Estes; Homie Razavi; Rohit Loomba; Zobair Younossi; Arun J Sanyal
Journal:  Hepatology       Date:  2017-12-01       Impact factor: 17.425

View more
  15 in total

1.  Inside-Out or Outside-In: Choosing the Right Model of Hepatocellular Cancer.

Authors:  Satdarshan P Monga
Journal:  Gene Expr       Date:  2020-06-05

Review 2.  Bile acid detergency: permeability, inflammation, and effects of sulfation.

Authors:  Michael Camilleri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-03-08       Impact factor: 4.052

3.  Gualou Xiebai Decoction ameliorates increased Caco-2 monolayer permeability induced by bile acids via tight junction regulation, oxidative stress suppression and apoptosis reduction.

Authors:  Jiyuan Su; Zhiqing He; Yunhua Yu; Mingfang Lu; Zonggui Wu; Dongmei Zhang
Journal:  J Bioenerg Biomembr       Date:  2021-10-31       Impact factor: 2.945

4.  Intestinal Barrier Dysfunction in Fatty Liver Disease: Roles of Microbiota, Mucosal Immune System, and Bile Acids.

Authors:  Biki Gupta; Ravi Rai; Michael Oertel; Reben Raeman
Journal:  Semin Liver Dis       Date:  2022-06-23       Impact factor: 6.512

Review 5.  Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).

Authors:  Xiaohan Xu; Kyle L Poulsen; Lijuan Wu; Shan Liu; Tatsunori Miyata; Qiaoling Song; Qingda Wei; Chenyang Zhao; Chunhua Lin; Jinbo Yang
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

6.  Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1/AMPK signaling in obese mice.

Authors:  Chian-Jiun Liou; Shu-Ju Wu; Szu-Chuan Shen; Li-Chen Chen; Ya-Ling Chen; Wen-Chung Huang
Journal:  Cell Biosci       Date:  2020-09-29       Impact factor: 7.133

Review 7.  Gut microbiome, liver immunology, and liver diseases.

Authors:  Rui Wang; Ruqi Tang; Bo Li; Xiong Ma; Bernd Schnabl; Herbert Tilg
Journal:  Cell Mol Immunol       Date:  2020-12-14       Impact factor: 11.530

Review 8.  Nutritional Components in Western Diet Versus Mediterranean Diet at the Gut Microbiota-Immune System Interplay. Implications for Health and Disease.

Authors:  Cielo García-Montero; Oscar Fraile-Martínez; Ana M Gómez-Lahoz; Leonel Pekarek; Alejandro J Castellanos; Fernando Noguerales-Fraguas; Santiago Coca; Luis G Guijarro; Natalio García-Honduvilla; Angel Asúnsolo; Lara Sanchez-Trujillo; Guillermo Lahera; Julia Bujan; Jorge Monserrat; Melchor Álvarez-Mon; Miguel A Álvarez-Mon; Miguel A Ortega
Journal:  Nutrients       Date:  2021-02-22       Impact factor: 5.717

9.  Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales.

Authors:  James K Carter; Dipankar Bhattacharya; Joshua N Borgerding; M Isabel Fiel; Jeremiah J Faith; Scott L Friedman
Journal:  PLoS One       Date:  2021-01-04       Impact factor: 3.240

Review 10.  Effect of different bile acids on the intestine through enterohepatic circulation based on FXR.

Authors:  Junwei Xiang; Zhengyan Zhang; Hongyi Xie; Chengcheng Zhang; Yan Bai; Hua Cao; Qishi Che; Jiao Guo; Zhengquan Su
Journal:  Gut Microbes       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.